Trace-Ability, Inc.

Medtech · Private

Tracer-ONE: compact automation system for production of Zr-89-radiolabeled monoclonal antibodies for PET imaging

Claim this profile

Follows are private to you and power your alerts

Updated Oct 23, 2026 · traceabilityinc.com

Sector: Medtech
Total capital: $16.6M

Federal grants: $16.6M; 20 awards · 2015–2026; Rank in peer group#21 of 538
Private capital raised: None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts: None on recordNo federal contract awards found.
Granted patents: 5; 3 pending · first 2019; Rank in peer group#111 of 538

Capital timeline

Latest events

May 2026Federal grantHealth and Human S · Phase II · Improving availability of ImmunoPET via automation of radio-synthesis and quality control of antibody-based HIV imaging PET tracers on a single platform.$1M
Apr 2025Federal grantHealth and Human S · Phase II · Enabling nationwide AD PET imaging to support most efficient clinical trials by adoption of radically simplified and standardized quality control in commercial production of AD PET tracers.$1.5M
Mar 2025Federal grantHealth and Human S · Phase II · Improving availability of ImmunoPET via automation of radio-synthesis and quality control of antibody-based HIV imaging PET tracers on a single platform.$1M
Aug 2024Federal grantHealth and Human S · Phase II · Enabling nationwide AD PET imaging to support most efficient clinical trials by adoption of radically simplified and standardized quality control in commercial production of AD PET tracers.$1.5M
Jan 2024Federal grantHealth and Human S · Phase II · Improving availability of ImmunoPET via automation of radio-synthesis and quality control of antibody-based HIV imaging PET tracers on a single platform.$1M
Jan 2022Federal grantHealth and Human S · Phase II · Enabling nationwide AD PET imaging to support most efficient clinical trials by adoption of radically simplified and standardized quality control in commercial production of AD PET tracers.$1.3M
Sep 2021Federal grantHealth and Human S · Phase I · Rapid pre-release sterility test for PET Drugs.$168K

Show 12 earlier federal awards

Jan 2021Federal grantHealth and Human S · Phase II · Enabling nationwide AD PET imaging to support most efficient clinical trials by adoption of radically simplified and standardized quality control in commercial production of AD PET tracers.$1.3M
Jul 2020Federal grantHealth and Human S · Phase II · Development of completely automated quality control procedures for 4 PET Imaging tracers that will increase production throughput and lead to expanded diversity of PET imaging available to patients.$811K
Sep 2019Federal grantHealth and Human S · Phase I · Improving availability of ImmunoPET via automation of radio-synthesis and quality control of antibody-based cancer imaging PET tracers on a single platform.$300K
Aug 2019Federal grantHealth and Human S · Phase II · Development of completely automated quality control procedures for 4 PET Imaging tracers that will increase production throughput and lead to expanded diversity of PET imaging available to patients.$1.5M
Jul 2019Federal grantHealth and Human S · Phase II · Development of completely automated quality control procedures for 4 PET Imaging tracers that will increase production throughput and lead to expanded diversity of PET imaging available to patients.$690K
Aug 2018Federal grantHealth and Human S · Phase II · Development of completely automated quality control procedures for 4 PET Imaging tracers that will increase production throughput and lead to expanded diversity of PET imaging available to patients.$232K
Dec 2017Federal grantHealth and Human S · Phase II · Analytical Methods for Automated Quality Control of Cancer PET Imaging Tracer - [F-18]FDG$1.2M
Dec 2016Federal grantHealth and Human S · Phase II · Analytical Methods for Automated Quality Control of Cancer PET Imaging Tracer - [F-18]FDG$860K
Mar 2016Federal grantNSF · Phase II · SBIR Phase II: Development of a simple device that eliminates bottlenecks in radiopharmaceutical production$1.1M
Feb 2015Federal grantHealth and Human S · Phase I · Analytical Methods for Automated Quality Control of Cancer PET Imaging Tracer - [F-18]FDG$150K
Feb 2015Federal grantHealth and Human S · Phase I · Analytical Methods for Automated Quality Control of Cancer PET Imaging Tracer - [F-18]FDG$150K
Jan 2015Federal grantNSF · Phase I · SBIR Phase I: Development of a simple device that eliminates bottlenecks in radiopharmaceutical production$150K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

1 record has no date or no amount, so it isn’t placed on the timeline.

Standing among 538 peers

Line = median

Medtech · Device

Federal grants#21 · top 4%
Granted patents#111 · top 21%
Linked publications#61 · top 11%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 5 granted of 8

Jul 18, 2024PendingViable Cell Detection And Protocol Implementing The SameUSPTOApplication 18395034
Jun 11, 2024GrantedMethod For Determining A Concentration Of A Synthesis Component In A Radiopharmaceutical SampleUSPTOUS 12,007,376
Dec 19, 2023GrantedMethod Of Determining Radiation Characteristic Of A SampleUSPTOUS 11,846,621

Show all 8 patent records

Viable Cell Detection And Protocol Implementing The SameJul 18, 2024 · Application 18395034Pending
Method For Determining A Concentration Of A Synthesis Component In A Radiopharmaceutical SampleJun 11, 2024 · US 12,007,376Granted
Method Of Determining Radiation Characteristic Of A SampleDec 19, 2023 · US 11,846,621Granted
Systems And Methods For Characterizing Radioactive AnalytesMay 11, 2021 · US 11,002,717Granted
Palette-based Systems For Analyte CharacterizationJan 19, 2021 · US 10,895,563Granted
System And Method For Radiosynthesis, Quality Control And Dose DispensingJun 4, 2019 · US 10,309,947Granted
Palette-based Systems For Analyte CharacterizationApplication PCTUS2015052448Pending
Method For Determining A Concentration Of A Synthesis Component In A Radiopharmaceutical SampleApplication 19704300Pending

Recent research by its founders

Quality Control Automation Solutions for PET Drug Production20250 cites
Economical droplet-based microfluidic production of [18F]FET and [18F]Florbetaben suitable for human use202120 cites
In Memory of Our Mentor20210 cites

TRACE-ABILITY INCShares a founder: ARKADIJ ELIZAROV
AdialanteSimilar federal contract value in Medtech · null in contracts
RESOLET LLCSimilar federal contract value in Medtech · null in contracts
Stevenson Engineering, LLCSimilar federal contract value in Medtech · null in contracts
DENCODA LLCSimilar federal contract value in Medtech · null in contracts
MOIRES INSTRUMENTS, LLCSimilar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through Oct 23, 2026. SBIR and STTR awards through Oct 21, 2026.